Psychotropics

Seminars in Perinatology

Volumn 21, Issue 2, 1997, Pages 154-159

  Goldaber, K G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; AMITRIPTYLINE PLUS PERPHENAZINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CHLORDIAZEPOXIDE PLUS CLIDINIUM BROMIDE; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; DIAZEPAM; DOXEPIN; EMITRIP; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; LORAZEPAM; MESORIDAZINE BESYLATE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; PERPHENAZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIORIDAZINE; TIOTIXENE; TIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ANXIETY NEUROSIS; CHEMICAL TERATOGENESIS; CLEFT LIP PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONSTIPATION; CRANIOFACIAL MALFORMATION; DEPRESSION; DRUG CONTRAINDICATION; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; GESTATIONAL AGE; HUMAN; HYPERACTIVITY; MUSCLE HYPOTONIA; NONHUMAN; ORTHOSTATIC HYPOTENSION; PREGNANCY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; TACHYCARDIA; TREMOR;

EID: 0030908234     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-0005(97)80059-6     Document Type: Article

References (44)

1. DeVane CL Pharmokinetics of the newer antidepressants: Clinical relevance Am J Med 97 suppl 6A 1994 6A 13S
2. Chambers CD Johnson KA Dick LM Birth outcomes in pregnant women taking fluoxetine N Engl J Med 335 1996 1010
3. Pastuszak A Schick-Boschetto B Zuber C Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) JAMA 269 1993 2246
4. Goldstein DJ Williams ML Pearson DK Fluoxetine-exposed pregnancies Clin Res 39 1991 768A
5. Briggs CG Freeman RK Yaffe SJ Drugs in pregnancy and lactation ed 4 1994 Williams and Wilkins Baltimore, MD
6. Miller LJ Psychiatric medication during pregnancy: understanding and mininmizing risks Psychiatr Ann 24 1994 69
7. (letter) Prentice A Brown R Fetal tachyarrhytmia and maternal antidepressant treatment BMJ 298 1989 190
8. Miller LJ Psychopharmacology during pregnancy Prim Care Update Obstet Gynecol 3 1996 79
9. Banister P Dafoe C Smith ESO Possible teratogenicity of tricyclic antidepressants Lancet 1 1972 838
10. Guram MK Gill TS Geber WF Teratogenicity of imipramine and amitriptyline in fetal hamsters Res Commun Psychiatr Behav 5 1980 275
11. Larsen V The teratogenic effects of thalidomide, imipramine HCL and imipramine-N-oxide HCL on white Danish rabbits Acta Pharmacol Toxicol 20 1963 186
12. Owaki Y Momiyama H Onodera N Effects of doxepin hydrochloride administered to pregnant rabbits upon the fetuses OYo Yakuri Pharmocometrics 5 1971 905
13. Heinonen OP Slone D Shapiro S Birth Defects and Drugs in Pregnancy 1977 Publishing Sciences Group Littleton, MA
14. Guram MS Gill TS Geber WF Comparative teratogencity of chlordiazepoxide, amitriptyline, and a combination of the two compounds in the fetal hamster Neurotoxicology 3 1982 83
15. Shuey DL Sadler TW Lauder JM Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors Teratology 46 1992 367
16. Bourke GM Antidepressant teratogenicity? Lancet 1 1974 98
17. Shearer WT Schreiner RL Marshall RE Urinary retention in a neonate secondary to maternal ingestion of nortriptyline J Pediatr 81 1972 570
18. Cowe L Lloyd DJ Dawling S Neonatal convulsions caused by withdrawal from maternal clomipramine BMJ 284 1982 1837
19. Ostergaard GZ Pedersen SE Neonatal effects of maternal clomipramine treatment Pediatrics 69 1982 233
20. Boringa JB de Jong GM Touw DJ Neonatal withdrawal symptoms following the use of clomipramine during pregnancy Nederlands Tijdschrift voor Geneeskunde 136 1992 1473
21. Jurand A Malformations of the central nervous system induced by neurotropic drugs in mouse embryos Dev Growth Differentiation 22 1980 61
22. Bracken MB Holford TR Exposure to prescribed drugs in pregnancy and association with congenital malformations Obstet Gynecol 58 1981 336
23. Aselton P Jick H Milunsky A First-trimester drug use and congenital disorders Obstet Gynecol 65 1985 451
24. Aarskog D Association between maternal intake of diazepam and oral clefts Lancet 2 1975 921
25. Rosenberg L Mitchell AA Parsells JL Lack of correlation of oral clefts to diazepam use during pregnancy N Engl J Med 309 1983 1982
26. Hartz SC Heinonen OP Shapiro S Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality N Engl J Med 292 1975 726
27. Milkovich L van den Berg BJ Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development N Engl J Med 291 1974 1268
28. St Clair SM Schirmer RG First trimester exposure to alprazolam Obstet Gynecol 80 1992 843
29. Esaki K Tanioka Y Tsukada M Teratogenicity of lorazepam (WY-4036) in mice and rats CIEA Preclini Reports 1 1975 25
30. (suppl 3) Yonkers KA Cunningham FG Psychiatric Disorders Complicating Pregnancy ed 19 1993 Appleton & Lange, Williams Obstetrics Norwalk, CT
31. Sexson WR Barak Y Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy J Perinatol 9 1989 170
32. Elia J Katz IR Simpson GM Teratogenicity of psychotherapeutic medications Psychopharmacol Bull 28 1987 531
33. Slone D Sisking V Heinanen OP Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score Am J Obstet Gynecol 128 1977 486
34. Farkas VG Farkas G Teratogenic action of hyperemesis in pregnancy and of medication used to treat it Zentralbl Gynakol 10 1971 325
35. Rumeau-Rouquette C Goujard J Huel G Possible teratogenic effects of phenothiazines in human beings Teratology 15 1977 57
36. van Waes AV van de Velde E Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum J Clin Pharmacol 9 1969 224
37. Scanlon FJ The use of thioridazine (Melleril) during the first trimester Med J Aust 1 1972 1271
38. Owaki Y Momiyama H Yokoi Y Teratological studies on thiothixene (NavaneR) in mice Oyo Yakuri Pharmocometrics 3 1969 315
39. (abstr) vanRyzin RJ Carson SE Hartman HA Animal safety evaluation studies on the antipsychotic phenothiazine, mesoridazine Toxicol Appl Pharmacol 19 1971 363
40. Szabo KT Brent RL Species differences in experimental teratogenesis by tranquilizing agents Lancet 1 1974 565
41. (letter) Barnas C Bergant A Hummer M Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk Am J Psychiatry 151 1994 945
42. Weinstein MR Lithium treatment of women during pregnancy and in the post-delivery period Johnson FN Handbook of Lithium Therapy 1980 University Park Press Baltimore, MD
43. Kallen B Tandberg A Lithium and pregnancy. A cohort study on manic-depressive women Act Psychiatr Scand 68 1983 134
44. Cohen LS Friedman JM Jefferson JW A re-evaluation of risk of in utero exposure to lithium JAMA 271 1994 146